You are here

  • Home
  • Archive
  • Volume 93, Issue 2
  • Intracameral bevacizumab effectively reduces aqueous vascular endothelial growth factor concentrations in neovascular glaucoma

Article info

Article menu
Download PDFPDF
Letter
Intracameral bevacizumab effectively reduces aqueous vascular endothelial growth factor concentrations in neovascular glaucoma

Authors

  1. Dr S Grover, Department of Ophthalmology, University of Florida, 580 West 8th Street, Tower 2, 3rd Floor, Jacksonville, FL 32209, USA; sgrover{at}jax.ufl.edu
View Full Text

Citation

Grover S, Gupta S, Sharma R, et al
Intracameral bevacizumab effectively reduces aqueous vascular endothelial growth factor concentrations in neovascular glaucoma
British Journal of Ophthalmology 2009;93:273-274.

Publication history

  • Accepted June 4, 2008
  • First published July 10, 2008.
Online issue publication 
February 09, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2009 BMJ Publishing Group